Drug repurposing in the era of COVID-19: a call for leadership and government investment. | Med J Aust;212(10): 450-452.e1, 2020 06. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Drug repurposing in the era of COVID-19: a call for leadership and government investment.

Martin, Jennifer H; Bowden, Nikola A.

Affiliation

Martin JH; University of Newcastle, Newcastle, NSW.
Bowden NA; Hunter New England Health, Newcastle, NSW.

Med J Aust ; 212(10): 450-452.e1, 2020 06.

Article in En | MEDLINE | ID: mdl-32372435

Subject(s)
Key words

COVID-19; Drug industry; Drugs, generic; Infectious diseases; Medicine, traditional; Policy, drugs and alcohol; Respiratory tract infections; Virology

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Drug Repositioning / Financing, Government Limits: Humans Country/Region as subject: Oceania Language: En Journal: Med J Aust Year: 2020 Document type: Article Country of publication: Australia

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Drug Repositioning / Financing, Government Limits: Humans Country/Region as subject: Oceania Language: En Journal: Med J Aust Year: 2020 Document type: Article Country of publication: Australia